Israeli Prime Minister Netanyahu Undergoes Prostate Cancer Surgery

JERUSALEM — Israeli Prime Minister Benjamin Netanyahu underwent surgery Thursday to remove prostate cancer, a medical procedure that has temporarily removed him from his official duties. The operation took place at Sheba Medical Center in Tel Hashomer, where Netanyahu has received treatment for the condition since it was first disclosed earlier this year.

The surgery was performed under general anesthesia and is considered a standard treatment for the type of cancer diagnosed in the 74-year-old leader. Medical officials stated the procedure went as planned, though they declined to provide detailed information regarding the extent of the cancer or the specific surgical method used. Netanyahu is expected to remain in the hospital for several days for observation and initial recovery.

In a brief statement released by the Prime Minister's Office, Netanyahu's team confirmed the successful completion of the surgery and expressed gratitude for the public's support. The statement noted that Netanyahu will continue to monitor the situation from the hospital while delegating day-to-day governmental responsibilities to his deputy, Benny Gantz, who has been serving as acting prime minister during Netanyahu's previous medical absences.

The announcement comes amid ongoing political tensions in Israel, where Netanyahu faces pressure from opposition parties regarding his health and ability to lead during a period of heightened regional instability. Critics have questioned whether the Prime Minister should have waited to undergo surgery until after the current legislative session concluded, while supporters argue that prioritizing his health is essential for the stability of the government.

Netanyahu was diagnosed with prostate cancer in early 2026, a condition that has required multiple rounds of treatment. The cancer was detected during a routine medical checkup, and Netanyahu initially opted for a course of radiation therapy before deciding on surgical intervention. Medical experts have described the cancer as localized and treatable, with a high probability of full recovery.

The Prime Minister's health has been a subject of public concern, particularly given the ongoing conflict in the region and the need for decisive leadership. Netanyahu's absence from the Knesset and government meetings has raised questions about the continuity of policy decisions and the management of national security affairs.

As Netanyahu recovers, the focus remains on his long-term health outlook and the potential impact of his condition on Israeli politics. Medical officials have not yet provided a timeline for his return to full duties, though they expect him to be discharged within the week. The situation continues to develop as the Prime Minister's Office prepares to release further updates on his condition.